December 4, 2015
India’s Sun Pharmaceutical enters $2.5B US market with its generic version of Gleevec
Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec.